Literature DB >> 24668517

Clinical correlates of echocardiographic tissue velocity imaging abnormalities of the left atrial wall during atrial fibrillation.

Ione Limantoro1, Cees B de Vos2, Tammo Delhaas2, Bob Weijs2, Yuri Blaauw2, Ulrich Schotten2, Bas Kietselaer2, Ron Pisters2, Harry J G M Crijns2.   

Abstract

AIMS: In patients with atrial fibrillation (AF), echocardiographic tissue velocity imaging (TVI) enables assessment of electrical and structural remodelling by measuring, respectively, the AF cycle length (AFCL-TVI) and the atrial fibrillatory wall motion velocity (AFV-TVI). We investigated the clinical and echocardiographic correlates of atrial remodelling assessed by TVI. METHODS AND
RESULTS: We studied 215 patients presenting with AF. In all patients, we measured the AFCL-TVI and the AFV-TVI in the left atrium. Standard baseline characteristics were recorded. We divided patients by median value of AFV-TVI and AFCL-TVI to evaluate the determinants of atrial remodelling. A low AFV-TVI was related with a longer median duration of the current AF episode, a higher prevalence of significant mitral regurgitation and a thicker left ventricle (LV). Multivariate analysis revealed that a low AFV-TVI was independently associated with a longer median duration of the current AF episode [OR 0.09 (95% CI 0.03-0.027); P < 0.001]. Univariately, a short AFCL-TVI was associated with a long median duration of the current AF episode, the use of anti-arrhythmic drugs, a lower LV ejection fraction (LVEF) and a smaller left atrial volume index (LAVI). Multivariate analysis revealed that LVEF [OR 1.48 (95% CI 1.09-2.01); P = 0.013] and LAVI [OR 1.37 (95% CI 1.08-1.74); P = 0.010] were independently associated with AFCL-TVI.
CONCLUSION: This study investigated the clinical and echocardiographic correlates of atrial remodelling assessed by TVI. The AFV-TVI is reduced in patients with a long AF duration and who have mitral regurgitation. In addition, the AFCL is long if LAVI is high and LVEF preserved. Tissue velocity imaging parameters measured during AF may be helpful to characterize the degree of atrial remodelling and optimize treatment. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Atrial substrate; Echocardiography

Mesh:

Substances:

Year:  2014        PMID: 24668517     DOI: 10.1093/europace/euu047

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

1.  Cardioversion of persistent atrial fibrillation is associated with a 24-hour relapse gap: Observations from prolonged postcardioversion rhythm monitoring.

Authors:  Bob Weijs; Ione Limantoro; Tammo Delhaas; Cees B de Vos; Yuri Blaauw; Richard P M Houben; Sander Verheule; Ronny Pisters; Harry J G M Crijns
Journal:  Clin Cardiol       Date:  2018-03-22       Impact factor: 2.882

2.  Left atrial longitudinal strain in dilated cardiomyopathy patients: is there a discrimination threshold for atrial fibrillation?

Authors:  Jacek Kurzawski; Agnieszka Janion-Sadowska; Andrzej Gackowski; Marianna Janion; Łukasz Zandecki; Magdalena Chrapek; Marcin Sadowski
Journal:  Int J Cardiovasc Imaging       Date:  2018-10-19       Impact factor: 2.357

3.  Abnormal atrial strain with speckle-tracking echocardiography predicts the arrhythmic substrate of atypical right atrial flutter.

Authors:  Hiroshi Kawakami; Takayuki Nagai; Katsuji Inoue; Jitsuo Higaki; Shuntaro Ikeda
Journal:  HeartRhythm Case Rep       Date:  2017-02-24

4.  Left atrial appendage function assessment and thrombus identification.

Authors:  Jacek Kurzawski; Agnieszka Janion-Sadowska; Marcin Sadowski
Journal:  Int J Cardiol Heart Vasc       Date:  2016-12-10

5.  Left atrial mechanical remodelling assessed as the velocity of left atrium appendage wall motion during atrial fibrillation is associated with maintenance of sinus rhythm after electrical cardioversion in patients with persistent atrial fibrillation.

Authors:  Paweł Wałek; Janusz Sielski; Iwona Gorczyca; Joanna Roskal-Wałek; Katarzyna Starzyk; Elżbieta Jaskulska-Niedziela; Radosław Bartkowiak; Beata Wożakowska-Kapłon
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.